Literature DB >> 28214211

Expression of BMP-4 in papillary thyroid carcinoma and its correlation with tumor invasion and progression.

Xiaomei Meng1, Peng Zhu2, Ning Li2, Jinchen Hu3, Shaoguang Wang4, Shuguang Pang5, Jiahui Wang6.   

Abstract

Bone morphogenetic protein 4 (BMP-4) is a member of the BMP protein family. BMP-4 was reported to induce epithelial-mesenchymal transition (EMT) and promote tumor cell immigration and invasion. This study aimed to investigate the expression of BMP-4 in papillary thyroid carcinoma (PTC) and its correlation with the patients' clinicophathological features and with tumor invasion and metastasis. Surgically resected PTC specimens from 82 patients admitted to the Department of Thyroid Surgery of Yantai Yuhuangding Hospital between Feb 1st and May 31st, 2016 were collected. The expression level of BMP-4 in PTC tissues was examined by immunohistochemical staining. The full clinical records of all patients were collected to analyze the relevance between BMP-4 expression and the clinical pathological features of PTC. Our result showed that BMP-4-positive cell rate and staining intensity were positively correlated with the patient's age (P=0.031, 0.037), tumor size (P=0.033, 0.019), capsular invasion (P=0.001, 0.002) and TNM stage (P=0.001, 0.004), while not correlated with gender, multicentricity of tumor or lymphatic metastasis. In conclusion, this study identified BMP-4 as a potential molecular marker for predicting the invasion and progression of PTC.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Bone morphogenetic protein 4; Immunohistochemistry; Papillary thyroid carcinoma; Tumor progression

Mesh:

Substances:

Year:  2017        PMID: 28214211     DOI: 10.1016/j.prp.2017.01.008

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  6 in total

1.  Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4.

Authors:  P Zhao; W Ma; Z Hu; Y Zhang; S Zhang; Y Wang
Journal:  J Endocrinol Invest       Date:  2018-02-13       Impact factor: 4.256

Review 2.  The Dual Role of Bone Morphogenetic Proteins in Cancer.

Authors:  Duc-Hiep Bach; Hyen Joo Park; Sang Kook Lee
Journal:  Mol Ther Oncolytics       Date:  2017-10-24       Impact factor: 7.200

3.  A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome.

Authors:  Thibault Voeltzel; Mario Flores-Violante; Florence Zylbersztejn; Sylvain Lefort; Marion Billandon; Sandrine Jeanpierre; Stéphane Joly; Gaelle Fossard; Milen Milenkov; Frédéric Mazurier; Ali Nehme; Amine Belhabri; Etienne Paubelle; Xavier Thomas; Mauricette Michallet; Fawzia Louache; Franck-Emmanuel Nicolini; Claude Caron de Fromentel; Véronique Maguer-Satta
Journal:  Cell Death Dis       Date:  2018-09-27       Impact factor: 8.469

4.  Circular RNA expression and association with the clinicopathological characteristics in papillary thyroid carcinoma.

Authors:  Dan Guo; Fangyuan Li; Xiaoxiao Zhao; Bo Long; Sumei Zhang; Anqi Wang; Dingyan Cao; Jian Sun; Binglu Li
Journal:  Oncol Rep       Date:  2020-05-27       Impact factor: 3.906

5.  E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin.

Authors:  Qinyi Zhou; Jun Chen; Jialin Feng; Jiadong Wang
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

Review 6.  Early Steps of Mammary Stem Cell Transformation by Exogenous Signals; Effects of Bisphenol Endocrine Disrupting Chemicals and Bone Morphogenetic Proteins.

Authors:  Nora Jung; Veronique Maguer-Satta; Boris Guyot
Journal:  Cancers (Basel)       Date:  2019-09-12       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.